Intelligent Bio Solutions Inc. - SIC # 3840 -

Ticker Exchange SIC # Website Latest Ticker
INBS Nasdaq 3840 ibs.inc

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Intelligent Bio Solutions Inc.

Intelligent Bio Solutions Launches In-House Fingerprint Drug Testing Across 20+ Sites for Major Australian Waste Operator, Accelerating APAC Expansion - Jun 18th, 2025 6:30 am
EXCLUSIVE: Intelligent Bio's Fingerprint Drug Testing Gains Momentum With New Australian Rollout - Jun 18th, 2025 6:03 am
IBN Announces Latest Episode of The BioMedWire Podcast Featuring Harry Simeonidis, President and CEO of Intelligent Bio Solutions Inc. - Jun 17th, 2025 6:00 am
Intelligent Bio Solutions Expands U.S. Forensic Market Presence, Seeks FDA Clearance for Breakthrough Fingerprint Drug Testing - Jun 11th, 2025 6:30 am
EXCLUSIVE: Intelligent Bio Solutions Expands US Forensic Market Presence, Seeks FDA Clearance For Fingerprint Drug Testing - Jun 11th, 2025 6:01 am
IBN Coverage: Intelligent Bio Solutions (NASDAQ: INBS) Showcases Portable Drug Testing System at RISE25 - Jun 9th, 2025 11:30 am
IBN Coverage: Intelligent Bio Solutions (NASDAQ: INBS) Progressing with FDA Clearance for Fingerprint Drug Testing as Global Demand Grows - May 27th, 2025 11:30 am
IBN Coverage: Intelligent Bio Solutions (NASDAQ: INBS) to Showcase Fingerprint Drug Testing at RISE25 Conference - May 22nd, 2025 12:00 pm
Intelligent Bio Solutions to Showcase Fingerprint Drug Testing at RISE25 Conference from May 28-31, Supporting Innovation in U.S. Forensic Drug Testing - May 22nd, 2025 6:30 am
Intelligent Bio Solutions Showcases Rapid, Non-Invasive Drug Testing Capabilities in Remote Queensland Workforce Deployment - May 19th, 2025 6:30 am
IBN Coverage: Intelligent Bio Solutions (NASDAQ: INBS) Surpasses 450 Accounts as Fingerprint Drug Testing Expands Globally - May 15th, 2025 11:15 am
Intelligent Bio Solutions Accelerates Global Adoption of Fingerprint Drug Testing - May 15th, 2025 7:00 am
IBN Coverage: Intelligent Bio Solutions (NASDAQ: INBS) Grows Revenue, Cuts Losses in Fiscal Q3 as Cartridge Sales Drive Margins - May 13th, 2025 1:30 pm
Intelligent Bio Solutions Announces Fiscal Q3 2025 Financial Results and Key Operational Achievements - May 13th, 2025 6:30 am
EXCLUSIVE: Intelligent Bio Solutions Q3 Gross Profit Jumps By 91% - May 13th, 2025 6:00 am
Intelligent Bio Solutions Drives Global Growth Through Multilingual Digital Expansion - May 6th, 2025 6:30 am
Intelligent Bio Solutions Expands Global Reach with Latin American Spanish Language Integration into Drug Screening System - Apr 22nd, 2025 6:30 am
Intelligent Bio Solutions Expands Middle East Market Reach with Arabic Integration in Drug Screening System - Mar 31st, 2025 6:30 am
Intelligent Bio Solutions to Highlight Proprietary Drug Testing Technology at 2025 NDASA Conference and Trade Show - Mar 28th, 2025 6:30 am
Intelligent Bio Solutions Stock Drops Despite Key U.S. Patent Win - Mar 27th, 2025 8:48 am